ValueBasedPricing

Panel speakers at the Abarca Forward pharmacy conference discussed their outlooks for value-based drug pricing models by the end of the decade, coming up with four main predictions going . The first prediction, from Lyfegen’s CEO Girisha Fernando, is that the healthcare industry will have largely adopted a value-based pricing approach to drug formularies.